🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ASCO23 is well underway! My first big #ASCO. Thank you to Narjust Florez, MD, FASCO for inspiring the creation of this account after a powerful presentation yesterday. More on that later

🔥PROSPECT: Neoadjuvant chemoradiation versus neoadjuvant FOLFOX with selective use of chemoradiation, followed by TME for rectal cancer LARC #ASCO2023 👉most LARC can receive curative intent therapy without radiation ESMO - Eur. Oncology OncoAlert

Residency graduation ✅✅✅ Next stop: fellowship 🙏🏼

Breaking news 👉Finally significantly improved OS with adjuvant pembrolizumab in mRCC #kidneycancer 👉HR: 0.62, 38% reduction in death 👇Oral presentation AbsLBA359👉Terrific data &talk by perpetual practice changer Toni Choueiri, MD . Congrats team. Tom Powles OncoAlert Uromigos

Excited to share our case report of XRT for metastatic papillary RCC with ATM mutation. His disease remains stable 10 months after🛑all treatment. Great teamwork from Garrett Harada Dalia Kaakour, MD, MPH Michael Daneshvar UCI Health team!

Join us TODAY for the #CardioOnc webinar titled 'Multidisciplinary Approach for Managing Cardiotoxicities in Patients with Prostate Cancer' 👉 ow.ly/1HSI50ULHXt ⏰14:00 GMT | 09:00 EST Experts will discuss: ✅ Strategies to reduce cardiotoxic risks from cancer treatments

1/ JUST IN: an 8 year #kidneycancer journey now published in nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author David Braun Yale Cancer Center and #PatrickOtt #DerinKeskin

We are pleased to announce that hematology and oncology fellow Omid Yazdanpanah, MD was awarded a Conquer Cancer 2025 Genitourinary Cancers Symposium Merit Awards at the ASCO Genitourinary Cancers Symposium this week in San Francisco. This prestigious award recognizes

Hematology and oncology fellow Dalia Kaakour, MD, MPH, MS, stopped by the UCI Health booth at ASCO #GU25 to discuss findings from her research, presented in an abstract titled “Assessment of cardiovascular (CV) toxicity by providers in advanced prostate cancer (PCa) patients